Table 1.
Phenylephrine | Pseudoephedrine | |
---|---|---|
Adrenoceptor activity | Mainly α1 | β and α1 indirect |
CNS activity | None | weak stimulant |
Presystemic metabolism | Gut and liver | None |
Excretion in urine | 3% unchanged | 90% unchanged |
Cardiovascular effects | Hypertension bradycardia | Hypertension bradycardia |
Maximum dosage | 10–12.2 mg every 4 h | 60 mg every 4–6 h |
Tmax (h) plasma | 1.0–1.3 | 1.9 |
t1/2 | 2.0–3.0 | 5.4 |